Remote monitoring of implantable cardioverter-defibrillators: a systematic review and meta-analysis of clinical outcomes
Parthiban, Nirmalatiban, Esterman, Adrian, Mahajan, Rajiv, Twomey, Darragh J., Pathak, Rajeev K., Lau, Dennis H., Roberts-Thomson, Kurt C., Young, Glenn D., Sanders, Prashanthan, and Ganesan, Anand N. (2015) Remote monitoring of implantable cardioverter-defibrillators: a systematic review and meta-analysis of clinical outcomes. Journal of the American College of Cardiology, 65 (24). pp. 2591-2600.
PDF (Published Version)
- Published Version
Restricted to Repository staff only |
Abstract
Background: Remote monitoring (RM) of implantable cardioverter-defibrillators (ICD) is an established technology integrated into clinical practice. One recent randomized controlled trial (RCT) and several large device database studies have demonstrated a powerful survival advantage for ICD patients undergoing RM compared with those receiving conventional in-office (IO) follow-up.
Objectives: This study sought to conduct a systematic published data review and meta-analysis of RCTs comparing RM with IO follow-up.
Methods: Electronic databases and reference lists were searched for RCTs reporting clinical outcomes in ICD patients who did or did not undergo RM. Data were extracted from 9 RCTs, including 6,469 patients, 3,496 of whom were randomized to RM and 2,973 to IO follow-up.
Results: In the RCT setting, RM demonstrated clinical outcomes comparable with office follow-up in terms of all-cause mortality (odds ratio [OR]: 0.83; p = 0.285), cardiovascular mortality (OR: 0.66; p = 0.103), and hospitalization (OR: 0.83; p = 0.196). However, a reduction in all-cause mortality was noted in the 3 trials using home monitoring (OR: 0.65; p = 0.021) with daily verification of transmission. Although the odds of receiving any ICD shock were similar in RM and IO patients (OR: 1.05; p = 0.86), the odds of inappropriate shock were reduced in RM patients (OR: 0.55; p = 0.002).
Conclusions: Meta-analysis of RCTs demonstrates that RM and IO follow-up showed comparable overall outcomes related to patient safety and survival, with a potential survival benefit in RCTs using daily transmission verification. RM benefits include more rapid clinical event detection and a reduction in inappropriate shocks.
Item ID: | 46222 |
---|---|
Item Type: | Article (Research - C1) |
ISSN: | 1558-3597 |
Keywords: | home monitoring; mortality; shock; sudden cardiac death |
Funders: | University of Adelaide (UA), National Health and Medical Research Council (NHMRC) |
Date Deposited: | 19 Dec 2016 23:58 |
FoR Codes: | 11 MEDICAL AND HEALTH SCIENCES > 1102 Cardiovascular Medicine and Haematology > 110201 Cardiology (incl Cardiovascular Diseases) @ 100% |
SEO Codes: | 92 HEALTH > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions) > 920103 Cardiovascular System and Diseases @ 100% |
Downloads: |
Total: 8 |
More Statistics |